Rahway, NJ, United States of America

Alison J Frontier

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alison J Frontier: Innovator in Growth Hormone Release

Introduction

Alison J Frontier is a notable inventor based in Rahway, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that promote the release of growth hormone. Her innovative work has implications for both human health and agricultural efficiency.

Latest Patents

Alison holds 1 patent for her invention titled "Benzo-fused macrocycles promote release of growth hormone." This patent discloses novel compounds identified as benzo-fused macrocycles, which have the ability to enhance the release of growth hormone in both humans and animals. The application of these compounds can lead to more efficient production of edible meat products in food animals and can also aid individuals who suffer from a deficiency in natural growth hormone secretion.

Career Highlights

Alison is currently employed at Merck & Company, Inc., where she continues to advance her research in the field of growth hormone and its applications. Her work is pivotal in bridging the gap between scientific research and practical applications in medicine and agriculture.

Collaborations

Alison has collaborated with esteemed colleagues such as Robert Joseph Devita and William R Schoen. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Alison J Frontier's contributions to the field of growth hormone research exemplify the impact of innovative thinking in science. Her work not only addresses critical health issues but also promotes efficiency in food production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…